Stock & Company Details
Protagonist Therapeutics Inc $PTGX
Price:
46,691,331
64M
$7.9B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
PTGX technical indicators
Latest Protagonist Therapeutics Inc (PTGX) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
71.54 1.4%
MACD:
5.67 2.1%
SMA 50:
$104.79 0.3%
SMA 200:
$89.67 0.4%
EMA 20:
$113.26 0.9%
Bollinger Bands:
129 / 91.85
Stochastic:
83.11 2.5%
ADX 14:
41.80 2.9%
ATR 14:
4.97 0.3%
CCI 20:
104.11 5.9%
OBV:
85.22M 0.7%
ROC 12:
11.65% 22.3%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Finance Bot
Ask your questions
Start by typing a question below.
